International Congress on Neurodegenerative Diseases
19th - 21st SEPTEMBER 2024| LISBOA
We will start with a neuropathology session proposing that co-pathology is the norm in dementia, and most patients have several components: tau, amyloid, tdp43, alpha-synuclein.
CHAIRPERSON: Alberto Rábano . BTCIEN-Fundación CIEN.
Sandra Oliveira Tomé . KU-Leuven
“Title”
Gabor Kovacs . Laboratory Medicine & Pathobiology. University of Toronto. (On-line)
“Title”
Diego Sepúlveda . UKE Hamburgh
“Title”
Ed Lein . Allen Institute, Seattle
“Single cell transcriptomics & disease progression in Alzheimer's Disease”
In the following table, we will address how genetic variability is associated with the risk of AD and with most of the frequent AD co-pathologies (alpha-synuclein, TDP43, vascular…) and can potentially be applied to diagnostic and/or risk classification. We will also explore brain resilience from a genetic perspective.
CHAIRPERSON: Agustín Ruiz Fundació ACE-CIBERNED
Agustín Ruiz. Fundació ACE-CIBERNED
“Title”
Alfredo Ramírez . Cluster of Excellence for Aging Research. University of Cologne.
“Title”
Henne Holstege . Alzheimer Center Amsterdam. VUmc. Amsterdam UMC
“Title”
We will deepen into neuroimaging techniques for detecting different dementia-related patterns reflecting the disease components.
CHAIRPERSON: Michel Grothe. Fundación CIEN
David Wolk , Laboratory for Cognition and Neural Stimulation. University of Pennsylvania
"Title"
Jesús Silva. , Fundación CIEN
"Title"
Laura Jonkman, Amsterdam Neuroscience - Brain Imaging (VUmc). Amsterdam UMC
"Title"
Discussing the detection of neuropathological components in the periphery using biochemical markers.
CHAIRPERSON: Pascual Sánchez Juan Fundación CIEN
Gemma Salvadó . Clinical Memory Research. Lund University
"Title"
Anja Schneider. Translational Dementia Research. German Center for Neurodegenerative Diseases-DZNE. University of Bonn.
"Title"
Marc Suarez . Barcelona Beta Brain Research. Lund University
"Title"
